InvestorsHub Logo

Ecomike

09/23/20 7:22 PM

#16979 RE: Bivins #16971

ROLFLMA LOLOLOL

"And your right, makes much more sense that those product samples are collecting dust on a shelf somewhere and haven’t seen the light of day! LOL"

The $NDTP web site has arrived

http://www.NDTPharma.com

Ecomike

09/23/20 11:24 PM

#16980 RE: Bivins #16971

I can assure everyone here, that 10 to 13 years of iterations of $NDTP NPC-Nano Particle Complex "samples" have not gathered dust, and have in fact gone through various stages of trials and tests going back to 2007 where I tied the NDTP CEO Hovis and Professor Fountain together, and the 2010 Univ of Florida cutting edge, massive research where they tested NPCs with EGCG-green tea extract and some other nutrient extracts, and then the Hovis-Mathias-Kubin-Yarbrough-Fountain teams formed CCA, LLC (now $NDTP) to continue trials at UPennMed with Dr. Cohen, that led to public Info at the SEC in 2016 on CCA LLC (The 1st clue that led me to the whole story) where CCA, LLC, now $NDTP, trials at UPennMed, spanning 7 years now, using CCA, LLC/now NDTP NPC Nano Particle Complex Nano Delivery Technology that can cross the BBB Blood Brain Barrier, have traveled the path to where we are now.

The only thing that got dusted off was Milv shares now trading as $NDTP Biotech Nano Delivery Technology Pharmaceuticals Inc.

All the key research papers and Public records from research papers, to co-authors to Institutions to Patents all lead to $NDTP, Hovis/Kubin/Mathias/Yarbough, Professor Fountain and Dr. Cohen as key movers and shakers as well as the NIH National Institute of Health, US DOD, US Veterans Admin as key funding sources of the research.

And both Universities, 2010 and 2007 at Univ of So. Florida where Dr. Fountain created the Entrepreneur course curriculum, the same professor who was, imho, one of the fathers of the Liposome science and technology that so much Rx and non Rx Drug and product technology is built on today, and Univ of Penn-Med research Hospital since 2013 all the way to 2020 under a JV ownership of the UPennMed technology
all led to the birth of a ready to use, ready to rock and roll ND-Technology ready for use and marketing in drinks, oral IVs, Oral shots and for adaptation and use in delivering FDA approved drugs in a much more targeted, lower doze manner to the brain, in my not so humble opinion.

Yes that was once sentence. :-)

Lets rock and roll $NDTP fans, time for first contact with new highs to prove that resistance is futile as we take a magic carpet ride to fame and fortune and solve the brain trauma, brain damage repair quandaries so many people face.